Mark McDade, CEO at PDL BIOPHARMA, INC. (PDLI), sold 8,500 shares at $20.40 ($172K) on 2007-01-05, disclosed to the SEC on 2007-01-09.
Scheduled sale ($172k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.19 | 1,000 | $20K | 11.7% |
| 2 | $20.20 | 1,500 | $30K | 17.6% |
| 3 | $20.30 | 1,000 | $20K | 11.8% |
| 4 | $20.31 | 3,000 | $61K | 35.3% |
| 5 | $20.35 | 1,000 | $20K | 11.8% |
| 6 | $20.40 | 1,000 |
| $20K |
| 11.8% |
| Total | $20.29 avg | 8,500 | $172K | 100% |
| Filing → |
| AIMT | BUY | 2015-08-11 | $267K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |